Persistent ascites after ovarian hyperstimulation syndrome and administration of mifepristone (RU 486) for the termination of pregnancy.
We describe two cases with persistent ascites after ovarian hyperstimulation syndrome (OHSS). Mifepristone (RU 486), an anti-progestin was administered to terminate pregnancy in both cases.


CONCLUSIONS
To our knowledge, this is the first such report and we discuss the implications.
Gnoth
Christian
C
Department of Reproductive Medicine and Gynaecological Endocrinology, Kliniken der Landeshauptstadt Düsseldorf GmbH, Frauenklinik Benrath, Urdenbacher Allee 83, 40593 Düsseldorf, Germany. gnoth@uni-duesseldorf.de
Halbe
Elisabeth
E
Freundl
Günter
G
D000021:Abortifacient Agents, Steroidal / Q000494:pharmacology*; D000028:Abortion, Induced; D000328:Adult; D001201:Ascites / Q000000981:diagnostic imaging / Q000209:etiology*; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D015735:Mifepristone / Q000494:pharmacology*; D016471:Ovarian Hyperstimulation Syndrome / Q000150:complications* / Q000000981:diagnostic imaging; D011247:Pregnancy; D020554:Sperm Injections, Intracytoplasmic; D014463:Ultrasonography
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone